ResMed, a $3.5 billion US based medical devices manufacturer, today announced the launch of its marketing operations in India, through a partnership with a local company Respicure Medsys.

The company plans to target the major metros and tier two cities like Chandigarh, Jaipur, Lucknow and others in India, initially. The company's Asia Pacific headquarters is based in Sydney, Australia.

ResMed is a leading medical device developer, manufacturer and marketer for diagnosis and treatment of Sleep Disordered Breathing (SDB) and non-invasive and invasive ventilation products. SDB affects around 20 per cent of the adult world population. The disease is equally widespread as asthma and diabetes but the awareness is low and 90 per cent of affected people remain undiagnosed and untreated, said a company release.

Paul Eisen, senior vice president and head of ResMed Asia Pacific Ltd., said, "ResMed's leading edge technology in CPAP and mask solutions will now be accessible to the Indian people through our partnership with local company Respicure Medsys. And although we are well known for our sleep business, we clearly believe that our ventilation product range will service the growing number of Indian people that require both invasive and non-invasive ventilation."

Puneet Sahai, managing director of India Operations, said, "Establishing a direct set up and the addition of talented and experienced staff from India will allow ResMed to provide the benefits of its superior product offering and services for the huge number of people affected by sleep disorders."

ResMed offers integrated solutions for sleep disordered breathing like Continuous Positive Airway Pressure (CPAP), Automatic Positive Airway Pressure (APAP), Bilevel and Adaptive Servo Ventilation Therapy. It also offers mask technology and humidification options and curing devices ranging from Continuous Positive Airway Pressure (CAPA) Devices, Autotitration Devices, Bilevel Devices, Nasal Pillow Systems, Nasal Masks, Face Masks, Heated Humidifiers and Passive Humidifiers.

Sources said the Asia Pacific operations contribute 10 per cent of the total revenue of the company. ResMed is in the list of Fortune magazine's list of America's 100 Fastest-Growing Companies. It has over 2,500 employees worldwide and distributes to over 65 countries with direct offices and distribution partners. In Asia Pacific Limited ResMed has offices in Australia, New Zealand, Japan, and Hong Kong, Singapore. India and China are the new offices opened this year.